{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jia Z"],"funding":["China Pharmaceutical University"],"pagination":["966"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8539665"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(10)"],"pubmed_abstract":["Scaffold-based peptides (SBPs) are fragments of large proteins that are characterized by potent bioactivity, high thermostability, and low immunogenicity. Some SBPs have been approved by the FDA for human use. In the present study, we developed SBPs from the venom gland of <i>Deinagkistrodon acutus</i> (<i>D. acutus</i>) by combining transcriptome sequencing and Pfam annotation. To that end, 10 Kunitz peptides were discovered from the venom gland of <i>D. acutus</i>, and most of which peptides exhibited Factor XIa (FXIa) inhibitory activity. One of those, DAKS1, exhibiting strongest inhibitory activity against FXIa, was further evaluated for its anticoagulant and antithrombotic activity. DAKS1 prolonged twofold APTT at a concentration of 15 μM in vitro. DAKS1 potently inhibited thrombosis "],"journal":["Pharmaceuticals (Basel, Switzerland)"],"pubmed_title":["DAKS1, a Kunitz Scaffold Peptide from the Venom Gland of <i>Deinagkistrodon acutus</i> Prevents Carotid-Artery and Middle-Cerebral-Artery Thrombosis via Targeting Factor XIa."],"pmcid":["PMC8539665"],"funding_grant_id":["CPU2018GY15"],"pubmed_authors":["Liu Y","Li H","Zheng Y","Li Z","Ji X","Jiang S","Kong Y","Jia Z"],"additional_accession":[]},"is_claimable":false,"name":"DAKS1, a Kunitz Scaffold Peptide from the Venom Gland of <i>Deinagkistrodon acutus</i> Prevents Carotid-Artery and Middle-Cerebral-Artery Thrombosis via Targeting Factor XIa.","description":"Scaffold-based peptides (SBPs) are fragments of large proteins that are characterized by potent bioactivity, high thermostability, and low immunogenicity. Some SBPs have been approved by the FDA for human use. In the present study, we developed SBPs from the venom gland of <i>Deinagkistrodon acutus</i> (<i>D. acutus</i>) by combining transcriptome sequencing and Pfam annotation. To that end, 10 Kunitz peptides were discovered from the venom gland of <i>D. acutus</i>, and most of which peptides exhibited Factor XIa (FXIa) inhibitory activity. One of those, DAKS1, exhibiting strongest inhibitory activity against FXIa, was further evaluated for its anticoagulant and antithrombotic activity. DAKS1 prolonged twofold APTT at a concentration of 15 μM in vitro. DAKS1 potently inhibited thrombosis ","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Sep","modification":"2026-04-08T07:35:37.201Z","creation":"2024-11-20T09:25:52.401Z"},"accession":"S-EPMC8539665","cross_references":{"pubmed":["34681191"],"doi":["10.3390/ph14100966"]}}